Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Total Liabilities (Quarterly): 109.03M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 109.03M |
| March 31, 2024 | 108.32M |
| December 31, 2023 | 57.48M |
| September 30, 2023 | 50.80M |
| June 30, 2023 | 47.02M |
| March 31, 2023 | 97.68M |
| December 31, 2022 | 104.19M |
| September 30, 2022 | 95.85M |
| June 30, 2022 | 105.52M |
| March 31, 2022 | 169.22M |
| December 31, 2021 | 173.52M |
| September 30, 2021 | 74.10M |
| June 30, 2021 | 86.01M |
| March 31, 2021 | 79.92M |
| December 31, 2020 | 88.04M |
| September 30, 2020 | 73.97M |
| June 30, 2020 | 71.18M |
| March 31, 2020 | 51.13M |
| December 31, 2019 | 52.04M |
| September 30, 2019 | 44.61M |
| June 30, 2019 | 40.01M |
| March 31, 2019 | 40.01M |
| December 31, 2018 | 17.39M |
| September 30, 2018 | 43.92M |
| June 30, 2018 | 31.94M |
| Date | Value |
|---|---|
| March 31, 2018 | 30.33M |
| December 31, 2017 | 33.30M |
| September 30, 2017 | 30.02M |
| June 30, 2017 | 30.70M |
| March 31, 2017 | 31.82M |
| December 31, 2016 | 59.22M |
| September 30, 2016 | 52.99M |
| June 30, 2016 | 55.31M |
| March 31, 2016 | 54.17M |
| December 31, 2015 | 56.24M |
| September 30, 2015 | 56.76M |
| June 30, 2015 | 53.18M |
| March 31, 2015 | 52.20M |
| December 31, 2014 | 56.15M |
| September 30, 2014 | 7.083M |
| June 30, 2014 | 6.173M |
| March 31, 2014 | 6.752M |
| December 31, 2013 | 5.696M |
| September 30, 2013 | 4.331M |
| June 30, 2013 | 6.410M |
| March 31, 2013 | 4.882M |
| December 31, 2012 | 5.563M |
| September 30, 2012 | 4.748M |
| June 30, 2012 | 3.670M |
| March 31, 2012 | 7.295M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
44.61M
Minimum
Sep 2019
173.52M
Maximum
Dec 2021
86.98M
Average
82.97M
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk AS | 36.87B |
| Eli Lilly and Co | 58.24B |
| Altimmune Inc | 20.82M |
| Genmab AS | 1.098B |
| Viking Therapeutics Inc | 25.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.458B |
| Shareholders Equity (Quarterly) | 1.349B |
| Debt to Equity Ratio | 0.0295 |
| Current Ratio | 35.57 |
| Net Debt Paydown Yield | 0.04% |